Navigation Links
CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS

trial design to maximize our chances of demonstrating efficacy and supporting our commitment to help those who suffer from the devastating effects of ALS."

The double-blind, placebo-controlled rising multiple dose study, which was announced in February 2007, was designed to identify the highest safe and well-tolerated arimoclomol dose. Forty healthy volunteers were divided evenly into groups of 10 subjects. In each group three subjects received a placebo capsule without drug and seven received arimoclomol at either 100 mg (the highest dose provided in the Phase IIa double-blind and open-label extension studies), 200 mg, 400 mg, or 600 mg three times daily over a seven day period. Dose escalation proceeded carefully, with safety and tolerability demonstrated at lower dose levels prior to testing higher doses. The study indicated that all four doses were safe and well-tolerated. Based on these results and additional data, CytRx plans to proceed with a 400 mg dose of arimoclomol three times daily in its planned Phase IIb efficacy trial.

"While these results indicate that we could potentially use an even higher dose of arimoclomol, we selected 400 mg for our upcoming efficacy trial for several reasons," said Jack Barber, Ph.D., CytRx's Chief Scientific Officer. "First, the 400 mg dose resulted in drug serum exposures higher than those that have provided maximum therapeutic benefit in animals. Second, using less than the highest possible dose potentially provides a margin of safety for ALS patients. Finally, larger doses may not be practical in this population as the capsules could be too large for ALS patients who sometimes have difficulty swallowing."

CytRx is presently conducting a follow-up clinical trial in healthy volunteers to provide longer-term safety and tolerability information at the 400 mg dose. This double-blind, placebo-controlled study includes 16 healthy volunteers: four are receiving a placebo capsule without drug and 12 are receivi
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
2. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:12/15/2009)... newly formed industry, community and education initiative to advance ... is working to connect the orthopedics capital of the ... high-speed rail. ,, In a September report, ... World -- An overview, analysis and blueprint for ... statewide initiative to grow Indiana,s unique life sciences assets, ...
(Date:12/15/2009)... -- Medical researchers with EDP Biotech Corporation (EDP) ... technology for a simple blood test to detect ... success of its pre-clinical trials for the ColoMarker(TM) ... biomarker, CA11-19, and all aspects of its use. ... detect colon cancer in its earliest, most curable ...
(Date:12/15/2009)... find the best plan at the right price ... the end of the year, thousands of Nebraska Medicare ... coverage. This is when the state,s 268,000 Medicare ... sign up and pay for in 2010. ,, ... decision, says Independent Retail Pharmacist Steve Osenbaugh, of Lincoln. ...
Breaking Medicine Technology:OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 1URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 2URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 3URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 4More Stroke Victims Get Clot Busting Therapy 58706 1More Stroke Victims Get Clot Busting Therapy 58706 2More Stroke Victims Get Clot Busting Therapy 58706 3Iowa State researchers looking for catalyst that allows plants to produce hydrocarbons 10227 1Iowa State researchers looking for catalyst that allows plants to produce hydrocarbons 10227 2
... Next Generation CyberKnife System at Oklahoma ... CyberKnife ... ), a global leader in the field of radiosurgery,announced today that ... System that was recently,installed at the Oklahoma CyberKnife, LLC in Tulsa, ...
... III Study to Explore the Effects of Eligen(R) ... on Vertebral Fractures in Postmenopausal Women, CEDAR ... EMIS ) announced today that Novartis Pharma ... study exploring the,safety and efficacy of Salmon Calcitonin ...
Other Medicine Technology:New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times 2New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times 3New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times 4Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment 2
(Date:12/15/2009)... -- Knowledge Networks is significantly ... bio-tech research market with the acquisition of ... 11 years CMR has built and grown ... which now includes 70,000 U.S. physicians, and ... and hard-to-reach specialties. The Mount-Arlington, NJ-based ...
(Date:12/15/2009)... -- Patient advocate Betsy McCaughey, ... Congress that, "it doesn,t matter whether there,s a public ... a public option - give government authority over how ... a new social agenda by shifting billions of dollars ... arriving immigrants, and local politicians." ,, Betsy ...
(Date:12/15/2009)... 15 North American application activity for ... year-over-year, according to the MIB Life Index(SM) ... over the past three months have lifted year-to-date ... -1.6%, to flat at November,s close, -0.1%. ... in the benefits available from life insurance," says ...
(Date:12/15/2009)... A new study links chronic obstructive pulmonary disease, ... as sentinels to activate the body,s immune system. ... adds to growing awareness of the immune system,s role ... more than 12 million Americans with wheezing, shortness of ... is key if doctors are to find better ways ...
(Date:12/15/2009)... help, experts say , , TUESDAY, Dec. 15 (HealthDay News) ... how to spot the signs of stroke in relatives ... , Emergency medical treatment within three hours of the ... damage and lead to better recovery. , The Kids ... graders in Texas who were divided into two groups. ...
Breaking Medicine News(10 mins):Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Boosting Kids' Stroke IQ May Save Lives 2
... Is it a healthy, naturally occurring substance with many health ... GHB -- gamma hydroxy butyric acid -- hailed as a ... has been blamed as an illegal killer for the past ... emergency room visits, while others claim its unrivaled uses as ...
... created using information taken from a monkey gene ``dramatically ... laboratory experiment. The researchers believe the substance, which ... cells, but was lost to humans because of an ... University of California, Los Angeles, medical school, said he ...
... Alzheimer's is a degenerative brain disease that usually begins ... familiar tasks. How rapidly it advances varies from person ... personality and behavior changes and impaired judgment. Communication becomes ... high cholesterol appears to be bad for more than ...
... in fossil teeth has thrown new light on the recent ... human beings apart from their primate ancestors, according to an ... analysis of the fossil teeth, researchers from University College, London ... to 25 year development period of humans compared with 11 ...
... face a forewarning from severe periodontal disease than non-diabetic ... of periodontology.// ,Researchers from the University of Iowa ... diabetic and 20 non-diabetic women in their 20-39th week ... on the control of diabetes. They found the diabetics ...
... who eat up tomato products more than twice a ... cancer. Consuming cooked tomatoes was particularly beneficial, according to ... ketchup and other tomato-based foods lowered the prostate cancer ... Edward Giovannucci of Brigham and Women's Hospital and the ...
Other Medicine News:Health News:Scientists found ancient Human Germ Killer 2
The Guidant INSIGNIA Ultra pacing system offers sophisticated patient-specific, easy-to-use features for simplified patient management and enhanced patient safety....
... flexible, and fast, the HI VISION ... edge technologies with user-oriented operation for ... SONO MR package consists of advanced ... including HI COMPOUND multi-angle spatial compounding, ...
... provides a wide range of diagnosis by using ... to obtain a clear image of blood flow ... Flow Angio. An accessory elevator has been incorporated ... make it possible for more advanced and accurate ...
... ALX system is an expanded menu profiler ... as much as 50 percent and deliver ... Featuring the AccuSense® glucose oxygen sensor, enhanced ... menu, the CX9 ALX system offers general ...
Medicine Products: